Lutein is a carotenoid with anti-oxidant properties. Autophagy, an evolutionarily conserved catabolic cellular pathway for coping with stress conditions, is responsive to reactive oxygen species (ROS) and degrades damaged organelles. We previously demonstrated that lutein can induce anti-oxidant enzymes to relieve methotrexate-induced ROS stress. We therefore hypothesized that lutein, which activates ROS-scavenging enzymes, can also induce autophagy for cell survival. In this study, we demonstrated that lutein treatment attenuated the reduction in cell viability caused by HO. Lutein dose-dependently induced the processing of microtubule-associated protein light chain 3 (LC3)-II, an autophagy marker protein, and accumulation of LC3-positive puncta in rat intestinal IEC-6 cells. Furthermore, (a) direct observation of autophagosome formation through transmission electron microscopy, (b) upregulation of autophagy-related genes including ATG4A, ATG5, ATG7, ATG12, and beclin-1 (BENC1), and (c) increased BECN1/Bcl-2 ratio confirmed the induction of autophagy by lutein. The results revealed that bafilomycin-A1-induced inhibition of autophagy reduced cell viability and increased apoptosis in lutein-treated cells, indicating a protective role of lutein-induced autophagy. Lutein treatment also activated adenosine monophosphate-activated protein kinase (AMPK), c-Jun N-terminal kinase (JNK), and p-38, but had no effects on the induction of extracellular signal-related kinase or inhibition of mTOR; however, the inhibition of activated AMPK, JNK, or p-38 did not attenuate lutein-induced autophagy. Finally, increased BECN1 expression levels were detected in lutein-treated cells, and BECN1 knockdown abolished autophagy induction. These results suggest that lutein-induced autophagy was mediated by the upregulation of BECN1 in IEC-6 cells. We are the first to demonstrate that lutein induces autophagy. Elevated autophagy in lutein-treated IEC-6 cells may have a protective role against various stresses, and this warrants further investigation.
Ultraviolet rays are the main cause
of skin aging. Isoflavone structures
are good anti-ultraviolet natural compounds and have an especially
strong anti-ultraviolet B (UVB) effect. However, the anti-ultraviolet
A (UVA) effect of isoflavones is more controversial. Therefore, this
study aims to discover which isoflavone analogue possesses a strong
anti-ultraviolet A. We found the isoflavonoid intermediate deoxybenzoin-3A
(DOB-3A) to be a similar isoflavone structural compound with strong
anti-ultraviolet A effects. Ultraviolet rays with a wavelength of
350 nm are used to irradiate the fibroblasts of the human skin. Western
blot, flow cytometry, and transmission electron microscope analyses
were used to explore its anti-ultraviolet A mechanism. We established
the results that DOB-3A (1) reduced the death of fibroblasts caused
by ultraviolet A, (2) avoided the damage to the organelles and structures
after UVA irradiation, (3) inhibited the generation of intracellular
reactive oxygen species (ROS) and hydrogen peroxide-induced damage,
and (4) decreased the phosphorylation of mitogen-activated protein
kinases (MAPK) caused by UVA. Based on the above findings, DOB-3A
is a very good anti-ultraviolet A isoflavone-related structure. Because
it is simple to synthesize and has good effects, DOB-3A is a suitable
anti-ultraviolet A product with an isoflavone structure. Moreover,
DOB-3A’s structure provides a reference for the synthesis of
anti-UVA isoflavones.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.